Dr. Jim Kellner, a pediatrician and infectious disease expert at the University of Calgary, joins Global’s Joel Senick to discuss the significance of Pfizer-BioNTech’s Phase 3 trial results in children between the ages of 12 and 15.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.